Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × INDUSTRY × vorasidenib × Clear all

Status

Active not recruiting 2 Recruiting 1 Not yet recruiting 1 Completed 1 Approved for marketing 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Interventions

Injections 34 Carboplatin 27 Docetaxel 23 Oxaliplatin 22 Capecitabine 21 pembrolizumab 20 Paclitaxel 20 Cisplatin 19 Gemcitabine 16 Bevacizumab 16 Pemetrexed 14 Cyclophosphamide 12 Fluorouracil 11 tislelizumab 9 Leucovorin 9 Irinotecan 9 Drug Therapy 9 osimertinib 8 Doxorubicin 7 fludarabine 6 Trastuzumab 6 Nivolumab 6 palbociclib 5 lenvatinib 5 Topotecan 5 Prednisolone 5 Fulvestrant 5 Dexamethasone 5 130-nm albumin-bound paclitaxel 5 toripalimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06969352 2025-05-13

VICTORIA

Servier (Tianjin) Pharmaceutical Co. LTD.

Not yet recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡